Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Onyx Pharmac

Article Abstract:

The price appreciation potential of the shares of Onyx Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Emeryville, California-based company offers pharmaceutical products and associated therapies that are targeted at the molecular mechanisms implicated in cancer.

Author: Clark, Charles
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Pharmaceutical preparations, Evaluation, Pharmaceutical industry, Stocks, Stock prices, Onyx Pharmaceuticals Inc., ONXX

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Selection for growth: Psychiatric Sltn. (PSYS - 39.20)

Article Abstract:

The stock price stability and future earnings potential of stocks of Psychiatric Solutions, which provides behavioral-care services, are analyzed. The stocks of the company are expected to show good performance in next coming quarters.

Author: Maurer, Douglas G.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2007
Forecasts, trends, outlooks, Company business forecast/projection, Company forecasts, Psychiatric Solutions Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Health care industry, Securities, Company securities
Similar abstracts:
  • Abstracts: Agilent Tech. Selection for growth: Agilent Tech (A - 35.60)
  • Abstracts: Intel. Selection for growth: Intel Corporation (INTC-23.38)
  • Abstracts: Express Scripts, Inc. Selection for growth: Express Scripts (ESRX-95.94)
  • Abstracts: Psychiatric Sltn. Skillsoft PLC
  • Abstracts: Universal Health. Pediatrix Medical. NightHawk Rad'ogy
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.